# L-Carnitine Protective Effect in Nephrotoxicity

> **NCT07108777** · PHASE2 · RECRUITING · sponsor: **Tanta University** · enrollment: 46 (estimated)

## Conditions studied

- Nephrotoxicity

## Interventions

- **DRUG:** L-Carnitine Tartrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07108777
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-10
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07108777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07108777, "L-Carnitine Protective Effect in Nephrotoxicity". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT07108777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*